Asthma Clinical Trial
Official title:
Integrated Primary Care for Chronic Lung Diseases in Less Developed Countries: Pragmatic Trial of the Practical Approach to Care Kit in Brazil (PACK Brazil)
This study will evaluate a complex intervention based on a patient management tool (PMT), combined with educational outreach to primary care doctors, nurses and other health workers, in the Brazilian city of Florianopolis. The intervention is aimed at improving the quality of respiratory care and respiratory health outcomes, and comorbid conditions, in adults with asthma and chronic obstructive pulmonary disease (COPD). The effectiveness of the intervention will be assessed by randomly allocating 48 primary care clinics to receive the intervention or not, and comparing patient and clinic level endpoints that reflect the health and quality of care provided over the following year. About 1250 patients known to have been diagnosed with asthma and 700 with COPD in participating clinics and will be included in the study. The primary endpoints for patients with asthma and COPD, respectively, will be composite scores indicating appropriate prescribing and diagnostic testing. The third primary endpoint, among all adult clinic users, will be rates of new diagnoses of asthma and COPD in each clinic. Secondary endpoints will include the individual components of the composite scores, health measures (hospital admissions and deaths), and indicators of appropriate management of comorbid conditions such as cardiovascular risk factors. Eligible patients will be identified and outcomes measured using electronic medical records.
Long-lasting lung diseases like asthma and chronic obstructive lung disease (COPD) -
collectively called chronic respiratory disease (CRD) - place a heavy and growing burden on
people living in low and middle income countries. Many of them could be healthier if their
disease was accurately diagnosed and correctly treated, but many are not. Doctors and nurses
working in primary health care clinic are best placed people to diagnose and treat CRD,
especially where local clinics are near and free. But this raises three questions: 1. How to
ensure that CRDs get the priority they need in overloaded clinics? 2. How to train clinicians
to diagnose and manage CRDs without special test equipment? 3. How to ensure rational
evidence-based diagnosis and prescribing for CRD?
The investigators have developed a way of improving primary health care for people who have
CRD, who often also have other long term health conditions. It is a patient management tool
(PMT), that is, a printed manual of flowcharts taking doctors and nurses from symptoms to
diagnoses to treatments, tests or referrals, with advice on how to make decisions along the
way about diagnoses, tests, treatments and referrals. They are prompted to think of other
diseases and health problems that might be undetected or neglected. The package also includes
a method of training known as outreach education. First trainers are trained, then trainers
train groups of doctors and nurses at their workplaces, showing them how to use the
guidelines, and using their own patients and clinical problems as examples. This outreach
training is repeated several times in short sessions. The investigators' research in Africa
has shown that this approach can be effective, cost effective, feasible and sustainable. It
has been rolled out throughout South Africa and other African countries. But it has have not
yet been shown to be effective for this combination of diseases (CRDs together with
cardiovascular disease, diabetes, tuberculosis and back pain). The investigators have also
not tried or evaluate it in Latin American countries, which have different health systems,
and have many more doctors providing primary health care. Now co-investigators in the
Brazilian city of Florianopolis have decided to put this educational package in place
throughout the city, and have agreed to do so as a randomised controlled trial. This will
clearly show whether PACK Brazil is effective, cost effective and feasible under Brazilian
conditions.
The core of the research will be the randomised controlled trial. 48 primary care clinics in
the city will be randomly chosen either 1) to get the whole package of patient management
tool plus training, or 2) only to get the patient management tool (which we expect will make
little difference without training). The investigators will compare patients in these two
groups of clinics to see the effects of the training. They will use the clinics' electronic
medical records to identify about 2000 adults diagnosed with asthma or COPD. After the
training starts they will follow these patients up for a year, and assess whether they are
being appropriately treated and tested. They will also compare the rates of new diagnoses of
asthma and COPD in each clinic, and various health indicators.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|